february i wrote post i described evidence lilly antipsychotic olanzapine zyprexa marketed label dementia evidence i discussed based documents generously bravely hosted furious seasons time i careful avoid labeling practices illegal definitely unethical i could really say sure law broken however law firm known represent lilly regularly visiting website time made me think lilly seriously concerned legal troubles i suppose good reason worried i officially say label marketing zyprexa dementia criminal lilly admitted committing crime label marketing drug dementia settled legal charges cool billion cases still books really interesting take situation listen new york times reporter gardiner harris find talk embedded new york times story january linked plea agreement latest case available important remember pimping zyprexa dementia far victimless crime antipsychotics including zyprexa linked increased rate death elderly patients also shown little benefit placebo reducing dementia related symptoms disturbing account widespread inappropriate use medications read post weep truly case lust profits likely led early demise knows many patients talking dementia cases lilly went berzerk marketing zyprexa blame physicians much blame overuse antipsychotics elderly placed corporations lilly also true lilly directly administer drugs physicians need understand prescribing drugs found offer little benefit linked killing patients legitimately practicing medicine first harm yes i know dementia hell difficult condition handle mean doling ineffective potentially deadly treatments manage persons dementia yes reps lilly likely others wined dined physicians educating benefits zyprexa antipsychotics job positively spin products different used car salesperson except drug reps typically much better looking doctors need use critical thinking skills listen drug rep skim drug company provided journal article reprint jump zyprexa bandwagon learning evaluate evidence junky marketing disguised science persuade write inappropriate scripts yes outraged lilly others pimp ineffective dangerous treatments physicians important link better educated understand clinical trial results take time critically review scientific literature pattern repeat takes tricky pharmaceutical marketing combination audience unwilling think critically type tragedy occur occur unfortunately published scientific literature quite biased negative studies tend vanish rather grace pages journals still much better idea prescribers actually read journals critically examine findings opposed relying marketing alone better yet would research data medications negative positive available see